国际麻醉学与复苏杂志   2017, Issue (1): 9-9
    
盐酸羟考酮复合罗哌卡因用于剖宫产术后硬膜外自控镇痛的研究
王武涛, 赵玲, 舒雅, 韩彬, 雷茜, 张蓬勃1()
1.西安医学院第一附属医院
Clinical study of oxycodone hydrochloride combined with ropivacaine used in postoperative patient controlled epidural analgesia after cesarean section
 全文:
摘要:

目的 探讨剖宫产术后患者使用盐酸羟考酮复合罗哌卡因行硬膜外自控镇痛(patient controlled epidural analgesia, PCEA)的安全性、可行性以及治疗效果。 方法 选择择期剖宫产产妇60例,采用蛛网膜下腔联合硬膜外麻醉(combined spinal epidural anesthesia, CSEA),术后连接恒速镇痛泵与硬膜外导管。所有产妇采用随机数字表法分为3组(每组20例):芬太尼复合罗哌卡因组(FR组),2 mg/L芬太尼+0.15%罗哌卡因;盐酸羟考酮复合罗哌卡因组(OR组),100 mg/L盐酸羟考酮+0.15%罗哌卡因;盐酸羟考酮复合低浓度罗哌卡因组(ORL组),100 mg/L盐酸羟考酮+0.1%罗哌卡因。镇痛泵参数为:背景剂量2 ml/h,单次剂量为2 ml,锁定时间为30 min。记录产妇入手术室时(T0)、手术开始时(T1)及术后2 h(T2)、4 h(T3)、8 h(T4)、16 h(T5)、24 h(T6)、48 h(T7)和去除镇痛泵后2 h(T8)共9个时间点的MAP、HR、下肢运动神经阻滞评分(Bromage评分)、产妇静息时和按摩子宫时的VAS评分,统计药物总用量及副作用发生例数。 结果 按摩子宫时,VAS评分OR组[(3.4±0.5)分]和ORL组[(3.3±0.6)分]较FR组[(5.3±0.6)分]明显减轻(P<0.05);OR组和ORL组患者在整个镇痛期间镇痛药物用量[(103±5) ml和(102±6) ml]较FR组[(124±7) ml]明显减少(P<0.05);VAS评分和药物用量方面,OR组和ORL组差异无统计学意义(P>0.05)。 结论 盐酸羟考酮复合罗哌卡因用于剖宫产术后硬膜外自控镇痛安全可行,并且可以减少局部麻醉药的浓度和用量。

关键词: 盐酸羟考酮; 剖宫产术; 硬膜外自控镇痛
Abstract:

Objective To evaluate the feasibility, safety and effectiveness of oxycodone hydrochloride combined with ropivacaine used in patient controlled epidural analgesia(PCEA) after cesarean section. Methods Sixty patients underwent cesarean section following combined spinal epidural anesthesia(CSEA) and received PCEA were randomly divided into three groups: fentanyl and ropivacaine group(group FR): 2 mg/L fentanyl and 0.15% ropivacaine, oxycodone and ropivacaine group(group OR): 100 mg/L oxycodone hydrochloride and 0.15% ropivacaine, oxycodone and low dose of ropivacaine group(group ORL): 100 mg/L oxycodone hydrochloride and 0.1% ropivacaine. The drug was diluted with saline water to 150 ml. There were 20 patients for every group. Postoperative analgesia constant speed pump and the epidural catheters were connected for every patients at the end of operation. The pump was set for injection 2 ml/h and bolus for 2 ml, locking time 30 min. Patient′s MAP, HR, Bromage score, VAS, total amount of drugs and cases of adverse reactions were recorded into the operating room (T0), start operation (T1), 2 h after operation (T2), 4 h after operation (T3), 8 h after operation (T4), 16 h after operation (T5), 24 h after operation (T6), 48 h after operation (T7), 2 h after remove the pump(T8). Results The VAS score for the group OR (3.4±0.5), group ORL (3.3±0.6) and group FR(5.3±0.6) during massage uterus pain which group OR and group ORL decreased significantly compared with group FR(P<0.05). Total drug dosage of group OR[(103±5) ml] and group ORL[(102±6) ml] decreased more obviously than group FR[(124±7) ml](P<0.05). There was no significant difference between OR and ORL groups(P>0.05). Conclusions Oxycodone hydrochloride combined with ropivacaine can be safely and effectively used in PCEA after cesarean section. This combination also decrease the dose of local anesthetics in epidural anesthesia.

Key words: Oxycodone hydrochloride; Cesarean section; Patient controlled epidural analgesia